Form 4: DocGo Director Burdiek Granted 150,000 RSUs

DocGo Inc. Director Michael J. Burdiek was granted 150,000 restricted stock units, vesting in December 2026, under the company's 2021 Stock Incentive Plan.

Summary

• Michael J. Burdiek, a Director of DocGo Inc. (DCGO), acquired 150,000 shares of Common Stock.
• The acquisition occurred on December 12, 2025, and was in the form of restricted stock units (RSUs).
• These RSUs were granted pursuant to the Issuer's 2021 Stock Incentive Plan.
• Each RSU represents the right to receive one share of Common Stock upon vesting.
• The RSUs will vest on December 12, 2026.
• Following this transaction, Michael J. Burdiek beneficially owns 791,560 shares of Common Stock.
• The transaction price for the RSUs was $0, as they are a grant.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive due to the alignment of director interests with shareholders through equity compensation, which is a standard and expected corporate action.

Positives

• The grant of 150,000 restricted stock units to a director aligns management's long-term interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.

Future Outlook

The granted restricted stock units are scheduled to vest on December 12, 2026, indicating a future milestone for the compensation structure.

Industry Context

The grant of restricted stock units is a common form of equity compensation for directors and executives in publicly traded companies, aiming to incentivize long-term performance and align interests with shareholders. This practice is standard across various industries, including healthcare technology where DocGo operates.

Comparison to Industry Standards

• Equity-based compensation, such as RSU grants, is a standard practice for director remuneration in publicly traded companies across industries, including healthcare services and technology. This aligns with typical corporate governance structures designed to link executive and director incentives to shareholder value creation.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of RSUs to a director can be seen as a positive for shareholders as it aligns the director's financial interests with the company's long-term stock performance.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The 150,000 restricted stock units granted to Michael J. Burdiek are expected to vest on December 12, 2026.

Key Dates

Keywords

DocGo, DCGO, Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Stock Incentive Plan